Code: 06441683
There have been news reports with the tales of many community acquired bacterial infections that lead to serious hospitalisation. The last resort drug for these infections is vancomycin; an FDA approved glycopeptide antibiotic for ... more
English
155.61 €
RRP: 172.90 €
You save 17.29 €
Availability:
50/50
We think title might be available. Upon your order we will do our best to get it within 6 weeks.
Enter your e-mail address and once book will be available,
we will send you a message. It's that simple.
You get 377 loyalty points
Book synopsis
There have been news reports with the tales of many community acquired bacterial infections that lead to serious hospitalisation. The last resort drug for these infections is vancomycin; an FDA approved glycopeptide antibiotic for the treatment of several bacterial infections, including infections caused by susceptible staphylococcus, streptococcus, enterococcus, and diphtheroid organisms. Around the world in 1997, initial reports of reduced vancomycin susceptibility in clinical isolates of staphylococcus aureus generated significant concern in the medical community. There has been uncertainty regarding optimal laboratory tests and the clinical relevance of reduced vancomycin susceptibility in S. aureus; changes in the Clinical and Laboratory Standards Institute (CLSI) breakpoints for vancomycin against S. aureus; and increasing concern regarding the efficacy of vancomycin for the treatment of infection due to gram-positive bacteria, such as S. aureous. Vancomycin can be administered either intravenously or orally, but in order to treat systemic infections, vancomycin must be administered intravenously. Identifying the changes in genome content or expression, which are associated with the acquisition of the different types of vancomycin resistance, is an important step in the process of understanding the molecular basis of resistance with the potential to provide leads both for new drug targets and diagnostic biomarkers. However, considering that vancomycin has a slow bactericidal activity, clinicians have to adequately prescribe vancomycin to avoid the acquisition of resistance under therapy and to facilitate the cure.
Book details
Book category Books in English Medicine Nursing & ancillary services Nursing
155.61 €
English
Collection points Bratislava a 12619 dalších
Copyright ©2008-26 najlacnejsie-knihy.sk All rights reservedPrivacyCookies
25242 collection points
Delivery 2.99 €
02/210 210 99 (8-15.30h)Shopping cart ( Empty )